EdiGene Inc.
Edit the Code of Life, Creating Transformative Solutions for Serious Diseases.
46 employees · est. 2015 · Beijing, China
Poseida Therapeutics, Inc.
A Member of the Roche Group
81 employees · est. 2014 · San Diego, United States
Poseida Therapeutics, Inc. is the older company (2015 vs 2014); Poseida Therapeutics, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | EdiGene Inc. | Poseida Therapeutics, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2015 | 2014 older |
| Headquarters | ||
| Headquarters | Beijing, China | San Diego, United States |
| Employees | ||
| Employees | 46 | 81 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series B | Acquired |
| Total Funding | ||
| Total Funding | $180.04M | $1.88B |
| Funding Rounds | ||
| Funding Rounds | 6 | 9 |
| Services | ||
| Services | Gene Editing Technologies, RNA Editing Solutions, Cell and Gene Therapies, Therapeutic Development Platforms, High-Throughput Genomic Screening | Cell Therapy Development, Molecule Development, Patient Support Services, Clinical Trials Management, Scientific Research and Publications |
| Target Customers | ||
| Target Customers | Healthcare Providers, Biotech Researchers, Pharmaceutical Companies, Medical Practitioners, Patients with Genetic Disorders | Patients, Medical Professionals, Pharmaceutical Partners, Scientists, Healthcare Media |
| Taxonomy | ||
| Taxonomy | Gene Editing, Genetic Medicines, RNA Base Editing, Hematopoietic Stem Cell Editing, CAR-T Therapy, Genome Editing Technology, Molecular-Level Treatment, Gene Knockout, Gene Knock-in, Targeted Mutations, High Throughput Screening, Bioinformatics, Ex Vivo Gene Editing, In Vivo Gene Editing, Therapeutic Platforms | Allogeneic Cell Therapies, Genetic Medicines, Genome Engineering, CAR-T Products, Gene Editing, Non-viral DNA Delivery, Site-Specific Gene Editing System, Chimeric Antigen Receptor, Immunotherapy, Regenerative Medicine, Hematological Malignancies, Solid Tumors, Proprietary Genetic Platforms, In-house GMP Manufacturing, Oncology |
| Website | ||
| Website | edigene.com | poseida.com |
About EdiGene Inc.
EdiGene Inc., founded in 2015, is a clinical-stage biotech company based in China, dedicated to innovating through gene-editing technologies. Their motto, "Edit the Code of Life, Creating Transformative Solutions for Serious Diseases," captures the essence of their mission in the Biotechnology and H...
About Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc., now a Member of the Roche Group, is a clinical-stage biopharmaceutical company based in the United States. Initially founded in 2014, Poseida was acquired by Roche in early 2025, reinforcing its position in the biopharma and biotechnology industries. Pioneering in alloge...
We will tell you when either one moves
BounceWatch watches EdiGene Inc. and Poseida Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at EdiGene Inc. and Poseida Therapeutics,... — by email.
Frequently Asked Questions
Compare EdiGene Inc. with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at EdiGene Inc. on 15 Jun 2026, and Poseida Therapeutics, Inc. on 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.